万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
【简单介绍】
FormuMax,FormuMax代理,FormuMax北京代理,FormuMax中国,FormuMax脂质体,FormuMax Scientific,FormuMax Scientific脂质体,FormuMax Scientific代理【详细说明】
FormuMax,FormuMax代理,FormuMax北京代理,FormuMax中国,FormuMax脂质体,FormuMax Scientific,FormuMax Scientific脂质体,FormuMax Scientific代理
为更好的服务中国广大科研客户FormuMaxScientific从2013年开始正式授权上海起福生物科技有限公司为其中国授权代理,为广大科研工作者带来更好的服务感受。
FormuMax Scientific公司位于美国加州硅谷,是一家致力于为药物和生物技术研究提供制剂支持的专业公司。FormuMax拥有具有世界一流水平的药物传输技术团队,可以为基础研究、制剂可行性和客服定制制剂提供服务,尤其在基于脂质体制剂技术的特殊化合物传输方面有独特的优势和经验。
ClophosomeTM-氯膦酸二钠脂质体(中性)
ClophosomeTM,氯膦酸二钠脂质体,能高效地耗竭体内巨噬细胞。氯膦酸二钠分子被封装于小型多层脂质体中(MLV),具有高活性、理化稳定性、使用方便的特点。该剂型具有十分高的氯膦酸二钠/脂质比率。游离的氯膦酸二钠被清除,使得脂质体包封率超过90%。即使在冰箱中长期贮存后,该脂质体仍能保持均一悬浮状态。该品不粘稠,易于注射,且经过无菌过滤,保质期长。适用于多种给药途径,包括静脉注射、腹腔注射、皮下注射、鼻内给药、气管给药等。在单次静脉注射0.1mL24小时后,脾脏内巨噬细胞(红髓巨噬细胞)消除率为80-90%。为保证巨噬细胞耗竭的良好的一致性,对于体重为20-25g的动物,建议起始剂量为0.1-0.15mL(iv或ip)。我们建议您根据您的具体用途加以优化。
订购咨询电话:021-51875103
部分产品订购及报价信息如下:
| Product ID | Product Code | Description | Volume (mL) | Distributor Price |
| 1 | F10102 | Plain DPPC/CHOL Liposomes (55:45 mol/mol, 60mM, 100 nm) | 10 | 5385 |
| 2 | F10103 | Plain DSPC/CHOL Liposomes (55:45 mol/mol, 60mM, 100 nm) | 10 | 4035 |
| 3 | F10103B | Plain DSPC/CHOL Liposomes (67:33 mol/mol, 60mM, 100 nm) | 10 | 5235 |
| 4 | F10103C | Plain small DSPC/CHOL Liposomes (67:33 mol/mol, 60mM, 80 nm) | 10 | 5985 |
| 5 | F10104 | Plain HSPC/CHOL Liposomes (55:45 mol/mol, 60mM, 100 nm) | 10 | 3735 |
| 6 | F10105 | Plain 20:0PC/CHOL Liposomes (55:45 mol/mol, 60mM, 100 nm) | 10 | 5235 |
| 7 | F10106 | Plain 22:0PC/CHOL Liposomes (55:45 mol/mol, 60mM, 100 nm) | 10 | 5535 |
| 8 | F10107 | Plain 24:0PC/CHOL Liposomes (55:45 mol/mol, 60mM, 120 nm) | 10 | 7485 |
| 9 | F10108 | Plain PHSPC/CHOL Liposomes (55:45 mol/mol, 60mM, 100 nm) | 10 | 4935 |
| 10 | F10109 | Plain Pure DOPC Liposomes (60mM, 100 nm) | 10 | 4485 |
| 11 | F10110 | Plain Pure POPC Liposomes (60mM, 100 nm) | 10 | 5235 |
| 12 | F10202 | Plain DPPC/CHOL/mPEG2000-DSPE Liposomes (50:45:5 mol/mol, 60mM, 100 nm) | 10 | 5835 |
| 13 | F10203 | Plain DSPC/CHOL/mPEG2000-DSPE Liposomes (50:45:5 mol/mol, 60mM, 100 nm) | 10 | 4785 |
| 14 | F10204 | Plain HSPC/CHOL/mPEG2000-DSPE Liposomes (50:45:5 mol/mol, 60mM, 100 nm) | 10 | 4335 |
| 15 | F10205 | Plain 20:0PC/CHOL/mPEG2000-DSPE Liposomes (50:45:5 mol/mol, 60mM, 100 nm) | 10 | 5535 |
| 16 | F10206 | Plain 22:0PC/CHOL/mPEG2000-DSPE liposomes (50:45:5 mol/mol, 60mM, 110 nm) | 10 | 6285 |
| 17 | F10207 | Plain 24:0PC/CHOL/mPEG2000-DSPE Liposomes (50:45:5 mol/mol, 60mM, 120 nm) | 10 | 9435 |
| 18 | F20103A | DSPC/CHOL (55:45 mol/mol) Liposomes with Ammonium Gradient (60mM, 100nm) | 10 | 7035 |
| 19 | F20104A | HSPC/CHOL (55:45 mol/mol) Liposomes with Ammonium Gradient (60mM, 100nm) | 10 | 6585 |
| 20 | F20202A | DPPC/CHOL/mPEG2000-DSPE (50:45:5 mol/mol) Liposomes with Ammonium Gradient (60mM, 100nm) | 10 | 8685 |
| 21 | F20203A | DSPC/CHOL/mPEG-DSPE (50:45:5 mol/mol) Liposomes with Ammonium Gradient (60mM, 100nm) | 10 | 7185 |
| 22 | F20204A | HSPC/CHOL/mPEG2000-DSPE (50:45:5 mol/mol) Liposomes with Ammonium Gradient (60mM, 100nm) | 10 | 6435 |
| 23 | F20204AB | HSPC/CHOL/mPEG2000-DSPE (56.2/38.5/5.3) Liposomes with Ammonium Gradient (60mM, 100nm) | 10 | 8835 |
| 24 | F20204A-C | HSPC/CHOL (55:45 mol/mol) Liposomes with Ammonium Gradient (60mM, 100nm) | 10 | 5835 |
| 25 | F20204AS | SUV HSPC/CHOL/mPEG2000-DSPE (56.2/38.5/5.3) Liposomes with Ammonium Gradient (60mM, 80 nm) | 10 | 10485 |
| 26 | F20205A | 20:0 PC/CHOL/mPEG2000-DSPE (50:45:5 mol/mol) Liposomes with Ammonium Gradient (60mM, 110nm) | 10 | 8385 |
| 27 | F20206A | 22:0 PC/CHOL/mPEG2000-DSPE (50:45:5 mol/mol) Liposomes with Ammonium Gradient (60mM, 110nm) | 10 | 9435 |
| 28 | F20207A | 24:0 PC/CHOL/mPEG2000-DSPE (50:45:5 mol/mol) Liposomes with Ammonium Gradient (120nm) | 10 | 14085 |
| 29 | F30204B-C | Control liposomes for Doxoves®, 40mM | 2 | 2235 |
| 10 | 8835 | |||
| 30 | F30204B-D | Doxoves® - PEGylated Liposomal Doxorubicin (HSPC/CHOL/mPEG2000-DSPE, 56.2:38.5:5.3 mol/mol) 40mM, 4.0mg/mL | 2 | 4935 |
| 10 | 18435 | |||
| 31 | F30204C-D | Combo kit: Doxoves®-liposome doxorubicin and plain control liposomes | 2 | 5685 |
| 10 | 21285 | |||
| 32 | F50101 | Cationic Liposomes DMTAP/DOPE, 5mM, 80-10nm | 2 | 3585 |
| 10 | 12585 | |||
| 33 | F50102 | Cationic Liposomes DOTAP/DOPE, 5mM, 80-10nm | 2 | 2985 |
| 10 | 10485 | |||
| 34 | F50103 | Cationic Liposomes DDAB/DOPE, 5mM, 80-10nm | 2 | 2835 |
| 10 | 9885 | |||
| 35 | F50104 | Cationic Liposomes DODAP/DOPE, 5mM, 80-10nm | 2 | 2985 |
| 10 | 10485 | |||
| 36 | F50105 | Cationic Liposomes DC-CHOL/DOPE, 5mM, 80-10nm | 2 | 2985 |
| 10 | 10485 | |||
| 37 | F60103F-F | DOPC/CHOL Liposomes labeled with Fluorescein DHPE (F60103F-F), 50mM, 1% dye | 1 | 4485 |
| 5 | 17940 | |||
| 38 | F60103F-OG | DOPC/CHOL Liposomes labeled with Oregon Green 488 DHPE (F60103F-OG), 50mM, 1% dye | 1 | 5985 |
| 5 | 23940 | |||
| 39 | F60103F-R | DOPC/CHOL Liposomes labeled with Rhodamine DHPE (F60103F-R),50mM, 1% dye | 1 | 4485 |
| 5 | 17940 | |||
| 40 | F60103F-TR | DOPC/CHOL Liposomes labeled with Texas Red DHPE (F60103F-TR), 50mM, 1% dye | 1 | 5985 |
| 5 | 23940 | |||
| 41 | F60203F-F | DOPC/CHOL/mPEG-DSPE Liposomes labeled with Fluorescein DHPE (F60203F-F), 50mM, 1% dye | 1 | 5235 |
| 5 | 20940 | |||
| 42 | F60203F-OG | DOPC/CHOL/mPEG-DSPE Liposomes labeled with Oregon Green 488 DHPE (F60203F-OG), 50mM, 1% dye | 1 | 6735 |
| 5 | 26940 | |||
| 43 | F60203F-R | DOPC/CHOL/mPEG2000-DSPE Liposomes labeled with Rhodamine DHPE (F60203F-R), 50mM, 1% dye | 1 | 5235 |
| 5 | 20940 | |||
| 44 | F60203F-TR | DOPC/CHOL/mPEG-DSPE Liposomes labeled with Texas Red DHPE (F60203F-TR), 50mM, 1% dye | 1 | 6735 |
| 5 | 26940 | |||
| 45 | F70101C-N | Clophosome® - Clodronate Liposomes (Neutral) | 2 | 2985 |
| 10 | 10485 | |||
| 46 | F70101-N | Plain Control Liposomes for Clophosome® (Neutral) | 2 | 1485 |
| 10 | 5235 | |||
| 47 | F70101C-A | Clophosome-A(TM) - Clodronate Liposomes (Anionic) | 2 | 4485 |
| 10 | 15735 | |||
| 48 | F70101-A | Plain Control Liposomes for Clophosome-A(TM) (Anionic) | 2 | 2235 |
| 10 | 7785 | |||
| 49 | F70101C-AC | Combo kit: Clophosome-A(TM) and Control Liposomes | 2 | 5235 |
| 10 | 18285 | |||
| 50 | F70101C-NA | All-In-One Combo kit: Clophosome® and Clophosome- A(TM) And Controls | 2 | 8985 |
| 10 | 31485 | |||
| 51 | F70101C-NC | Combo: Clophosome® and Control Liposomes | 2 | 3585 |
| 10 | 12585 | |||
| 52 | F70101C-NAS | Evaluation Samples: Clophosome® and Clophosome-A(TM) | 1 | |
| Cliphosome-A is out of stock | 1 |
Agrenvec| http://www.ybiotechmall.com/enstyle/firstcatalog_3294116_Agrenvec_1.html;
Agilent| http://www.ybiotechmall.com/enstyle/firstcatalog_3294117_Agilent_1.html;
Agdia| http://www.ybiotechmall.com/enstyle/firstcatalog_3294118_Agdia_1.html;
AmeriBiopharma| http://www.ybiotechmall.com/enstyle/firstcatalog_3294119_AmeriBiopharma_1.html;
Amresco| http://www.ybiotechmall.com/enstyle/firstcatalog_3294120_Amresco_1.html;
Assay Designs| http://www.ybiotechmall.com/enstyle/firstcatalog_3294121_Assay-Designs_1.html;
Assaybiotech| http://www.ybiotechmall.com/enstyle/firstcatalog_3294122_Assaybiotech_1.html;
Assaypro| http://www.ybiotechmall.com/enstyle/firstcatalog_3294123_Assaypro_1.html;
Alexis| http://www.ybiotechmall.com/enstyle/firstcatalog_3294124_Alexis_1.html;
ATAGO| http://www.ybiotechmall.com/enstyle/firstcatalog_3294125_ATAGO_1.html;
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料





